Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol

dc.date.accessioned2017-09-14T13:30:47Z
dc.date.accessioned2018-03-15T17:56:08Z
dc.date.available2017-09-14T13:30:47Z
dc.date.available2018-03-15T17:56:08Z
dc.date.created2017-09-14T13:30:47Z
dc.date.issued1992
dc.identifierhttp://repositorio.umsa.bo/xmlui/handle/123456789/12448
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1173407
dc.description.abstractAbstract The electrocardiographic (ECG) changes in Bolivian patients with mucocutaneous leishmaniasis, treated with meglumine antimoniate and allopurinol, were evaluated. Electric changes due to the antimonial compound appeared in 45% of the patients, and consisted of repolarization alteration, principally affecting the T wave and the S-T segment. The changes disappeared within 2 months following the end of the antimonial treatment. In patients with associated Chagas disease and leishmaniasis, antimonial therapy did not aggravate the ECG changes characteristic of Chagasic cardiopathy.
dc.languageen
dc.publisherTransantions of The Royal Society of Tropical Medicine and Hygiene
dc.subjectLeishmaniasis mucocutánea
dc.subjectElectrocardiografía
dc.titleElectrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución